BOLERO-4: A PHASE 2, OPEN-LABEL, MULTICENTER, SINGLE-ARM TRIAL INVESTIGATING THE EFFICACY AND SAFETY OF FIRST-LINE EVEROLIMUS (EVE) IN COMBINATION WITH LETROZOLE (LET) IN POSTMENOPAUSAL PATIENTS (PTS) WITH ESTROGEN RECEPTORPOSITIVE (ER plus ), HUMAN EPIDE

Affiliation auteurs!!!! Error affiliation !!!!
TitreBOLERO-4: A PHASE 2, OPEN-LABEL, MULTICENTER, SINGLE-ARM TRIAL INVESTIGATING THE EFFICACY AND SAFETY OF FIRST-LINE EVEROLIMUS (EVE) IN COMBINATION WITH LETROZOLE (LET) IN POSTMENOPAUSAL PATIENTS (PTS) WITH ESTROGEN RECEPTORPOSITIVE (ER plus ), HUMAN EPIDE
Type de publicationJournal Article
Year of Publication2015
AuteursBachelot T, Villanueva C, Royce M, Debled M, Cruz FMelo, Hegg R, Brechenmacher T, Manlius C, Ringeisen F, Cardoso F
JournalBREAST
Volume24
PaginationS41
Date PublishedNOV
Type of ArticleMeeting Abstract
ISSN0960-9776
DOI10.1016/S0960-9776(15)30068-0